AIMS: This study aimed to determine the risk factors of survival in patients with
hepatocellular carcinoma (HCC) undergoing percutaneous radiofrequency ablation (PRFA) …

AIM: To investigate the long-term survival and prognostic factors in hepatocellular carcinoma
(HCC) patients undergoing radiofrequency ablation (RFA) as a first-line treatment …

Background: Radiofrequency ablation (RFA) is a curative modality for hepatocellular
carcinoma (HCC) patients who are not suitable for resection. It remains controversial …

Percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) was
introduced in Japan in 1999. It has been established as a main local treatment method …

Background and aims So far, no randomized trial or meta-analysis has been conducted on
overall survival (OS) and recurrence-free survival (RFS) factors in patients treated with …

AIM: To evaluate outcomes of radiofrequency ablation (RFA) therapy for early hepatocellular
carcinoma (HCC) and identify survival-and recurrence-related factors. METHODS …

OBJECTIVE. The purpose of our study was to assess the therapeutic results of
radiofrequency ablation of hepatocellular carcinoma (HCC) based on the histologic grades …

Hypothesis Radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) can be
performed by percutaneous or surgical approach. Tumor size is an important consideration …

Background: Radiofrequency ablation (RFA) is an alternative to hepatic resection and one of
the major therapeutic options for hepatocellular carcinoma (HCC). Here, we investigated the …

Background Hepatocellular carcinoma (HCC) frequently relapses after minimally invasive
treatment. This study aimed to observe the influencing factors of different recurrence patterns …